Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

28,000

Employees28,000

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

28,000

Employees28,000

AMGN Key Statistics

Market cap

158.01B

Market cap158.01B

Price-Earnings ratio

37.83

Price-Earnings ratio37.83

Dividend yield

3.19%

Dividend yield3.19%

Average volume

3.92M

Average volume3.92M

High today

$295.15

High today$295.15

Low today

$285.40

Low today$285.40

Open price

$286.63

Open price$286.63

Volume

2.49M

Volume2.49M

52 Week high

$346.85

52 Week high$346.85

52 Week low

$253.30

52 Week low$253.30

AMGN News

Benzinga 18h

Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug

Sandoz Group AG SDZNY SDZXF on Monday filed an antitrust lawsuit in the U.S. against Amgen, Inc. AMGN for extending and entrenching the dominant market position...

TipRanks 20h

Sandoz Files Antitrust Lawsuit Against Amgen Over Biosimilar Blockade

Sandoz Group Ltd ( (CH:SDZ) ) has shared an announcement. Sandoz has filed an antitrust lawsuit in the US against Amgen, Inc., alleging that Amgen has unlawful...

Seeking Alpha 23h

Amgen faces antitrust lawsuit from Sandoz over Enbrel patents

Generic drugmaker Sandoz (OTCQX:SDZXF) announced on Monday the filing of an antitrust lawsuit alleging that Amgen (NASDAQ:AMGN) used certain patent-related tact...

Analyst ratings

45%

of 31 ratings

Buy

45.2%

Hold

45.2%

Sell

9.7%

More AMGN News

TipRanks 1d

Sandoz Files Antitrust Lawsuit Against Amgen Over Enbrel Market Dominance - TipRanks

...